MedCity News
APRIL 25, 2025
Technology has the power to revolutionize treatment, make it more widely available, provide additional patient insight, and ultimately, alleviate the strain on our already stressed healthcare system. The post Community-Driven Digital Solutions Can Transform Addiction Treatment and Ease the Burden on the Healthcare System appeared first on MedCity News.
PharmaVoice
APRIL 25, 2025
A look at the government’s far-reaching rollback in research grants so far.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
APRIL 25, 2025
Caribou Biosciences restructuring narrows the biotechs focus to two off-the-shelf cell therapies for blood cancers, whose key data readouts have been pushed out to the second half of 2025. Its the CRISPR-editing companys second cash-saving restructuring in the past year. The post CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies appeared first on MedCity News.
Pharma Marketing Network
APRIL 25, 2025
Introduction In todays complex healthcare environment, what does it truly mean to practice Integrated Marketing Communications in pharma? For brands like Keytruda , Humira , and Ozempic , success isnt just about having a powerful product. Its about delivering consistent, engaging messages across a fragmented media landscape. Much like a symphony that requires every instrument to be in sync, pharma marketers must harmonize every touchpoint to resonate with both healthcare professionals and patien
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
APRIL 25, 2025
Orchestra BioMeds hypertension treatment is the latest medical device to earn the FDAs breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers. The post Orchestra BioMeds Hypertension Device Wins FDA Breakthrough Designation appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
APRIL 25, 2025
[Sponsored] Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better. The post 5 Major Trends Emerging in Healthcare Benefits in 2025 appeared first on MedCity News.
Pharma Marketing Network
APRIL 25, 2025
Introduction In the age of digital disruption and evolving patient expectations, does Referral Marketing hold any real value in the pharmaceutical space? Think about this: when a friend recommends a restaurant, youre far more likely to try it. The same psychology applies in healthcare, though with significantly higher stakes. As pharma brands like Ozempic and Dupixent seek to establish deeper connections with prescribers and patients, referral-based strategies are increasingly being tested acros
MedCity News
APRIL 25, 2025
We need intelligent, scalable systems that lift burdens, illuminate connections, and empower healthcare professionals to deliver their highest-quality care. Agentic AI provides this essential capability. The post Agentic AI and the Architecture of Healthcare Transformation appeared first on MedCity News.
Pharma Marketing Network
APRIL 25, 2025
Introduction In a rapidly evolving healthcare landscape, how can your Pharma Network stay ahead of the curve? As pharmaceutical brands face an unprecedented wave of digital transformation, strategic innovation, and shifting regulatory landscapes in 2025, optimizing your network has never been more critical. Much like upgrading an outdated GPS for an unknown journey, refreshing your pharma connections will determine whether your brand thrives or struggles in the new era.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Scott Burrows
APRIL 25, 2025
Competition can be intense. Whether its a rising competitor gaining momentum, an industry shift diminishing demand for your services, or a long-time rival slowly edging you out, its easy to feel cornered. But setbacks dont have to dictate your future. Instead, they can propel you forward. Rather than feeling trapped by competition, use it as a catalyst for growth, innovation, and renewed purpose.
pharmaphorum
APRIL 25, 2025
Ozempic patient blinded by NAION sues Novo Nordisk Jonah.
PharmaTimes
APRIL 25, 2025
MHRA authorises drug for adults with rare heart muscle damage
pharmaphorum
APRIL 25, 2025
Akeso has bagged an FDA approval for its PD-1 inhibitor penpulimab and reported new data on highly-touted PD-1/VEGF bispecific ivonescimab.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmaceutical Technology
APRIL 25, 2025
Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.
pharmaphorum
APRIL 25, 2025
Merck KGaA has confirmed that talks to buy SpringWorks have advanced to the 'late-stage' and are revolving around an offer of around $47 per share
Pharmaceutical Commerce
APRIL 25, 2025
Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.
Pharmacy Times
APRIL 25, 2025
A panelist discusses how recent clinical trials for EGFR-positive nonsmall cell lung cancer (NSCLC) have expanded treatment options beyond single oral agents, with studies like FLAURA2, MARIPOSA, and PAPILLON demonstrating significant improvements in progression-free survival for combination therapies such as osimertinib plus chemotherapy and amivantamab plus lazertinib, though these combinations often come with higher rates of toxicity, discontinuation, and adverse effects compared to monothera
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
APRIL 25, 2025
AbbVie is hoping to extend its range of neurotoxin-based pharma and cosmetic products with a short-acting successor to its blockbuster Botox brand.
Pharmacy Times
APRIL 25, 2025
A panelist discusses how combining therapies for EGFR-positive nonsmall cell lung cancer (NSCLC) increases both benefits (improved progression-free survival, response rates, and duration of response) and adverse effects, emphasizing that treatment selection should consider patient-specific factors like central nervous system (CNS) metastases, performance status, treatment aggressiveness preferences, and real-world limitations where patients often differ from clinical trial populations in terms o
pharmaphorum
APRIL 25, 2025
Our round-up of recent biotech financings includes rounds for Granite Bio, Biolinq, Etiome, Grove Biopharma, and Synthetic Design Lab
PharmaTimes
APRIL 25, 2025
Cambridge firm in-licenses two oncology programmes
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmaTech
APRIL 25, 2025
Under the partnership, Pharmaron will validate and promote the application of CN Bios PhysioMimix technology and will integrate OOC technologies into its R&D platform.
Pharmaceutical Technology
APRIL 25, 2025
Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per share.
PharmaTech
APRIL 25, 2025
The AbYlink technology enables a seamless, reproducible conjugation of payloads to antibodies or ADCs.
PharmExec
APRIL 25, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Commerce
APRIL 25, 2025
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of Theratechnologies, explains what the mindset be for companies who are just starting the reshoring process.
PharmExec
APRIL 25, 2025
Approval of penpulimab-kcqx marks the companys US regulatory debut and introduces a new immunotherapy option for advanced nasopharyngeal carcinoma.
PharmaTech
APRIL 25, 2025
This episode of Drug Digest will discuss where the significant bottlenecks are in the development and manufacturing of new molecules resulting from progressive technologies, such as AI and ML, and how best to approach these challenges.
Expert insights. Personalized for you.
272 
Let's personalize your content